Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1998
12/29/1998US5854217 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
12/29/1998US5854216 Marker for growth hormone-releasing factor receptors
12/29/1998US5854215 Modulators of β-amyloid peptide aggregation
12/29/1998US5854214 Therapeutic uses of bactericidal/permeability increasing protein products
12/29/1998US5854211 Compounds with growth hormone releasing properties
12/29/1998US5854209 Method for oxygenating tissue having reduced red blood cell flow
12/29/1998US5854208 Hepatoselective pharmaceutical actives
12/29/1998US5854206 Compounds and methods for treatment and diagnosis of prostate cancer
12/29/1998US5854205 Therapeutic antiangiogenic compositions and methods
12/29/1998US5854204 Aβ peptides that modulate β-amyloid aggregation
12/29/1998US5854203 Tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2
12/29/1998US5854202 Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same
12/29/1998US5854071 OP-3- induced morphongenesis
12/29/1998US5854067 Hexokinase inhibitors
12/29/1998US5854055 Recombinant mycobacteria
12/29/1998US5854053 Bacillus thuringiensis bacteria
12/29/1998US5854049 Plasmin-resistant streptokinase
12/29/1998US5854044 Recombinant pseudomonas exotoxin with increased activity
12/29/1998US5854041 Myoglobin with peroxidase activity
12/29/1998US5854037 Recombinant negative strand RNA virus expression systems and vaccines
12/29/1998US5854028 Compositions comprising IL-11 and methods of making and using IL-11
12/29/1998US5854026 Human growth hormone variant having enhanced affinity for human growth hormone receptor at site 1
12/29/1998US5854025 IGF-II analogues
12/29/1998US5854024 Hepatitus B vaccine
12/29/1998US5854022 Polynucleotides encoding a CD53-like transmembrane protein
12/29/1998US5854021 Enhance protein production method
12/29/1998US5854020 TCSTS polynucleotides
12/29/1998US5854018 Expression of polypeptides in yeast
12/29/1998US5854016 Creba Isoform
12/29/1998US5854004 Process for screening substances capable of modulating a receptor-dependent cellular signal transmission path
12/29/1998US5854003 Screening method for agents that modulate human NIK activity
12/29/1998US5854002 Method of identifying compounds that bind to the insect gaba receptor
12/29/1998US5854001 Hepatitis C virus fusion proteins
12/29/1998US5853999 Methods of screening for agents that inhibit interaction between MHC class I antigens and a cell surface receptor
12/29/1998US5853991 PCR-based cDNA subtractive cloning method
12/29/1998US5853988 Diagnosis of retinoblastoma
12/29/1998US5853987 Decorin binding protein compositions and methods of use
12/29/1998US5853985 Promoter of the gene for the human precursor of the alzheimer's disease and its use
12/29/1998US5853984 Use of nucleic acid ligands in flow cytometry
12/29/1998US5853978 Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
12/29/1998US5853975 Methods for identifying compositions for the treatment of body weight disorders, including obesity
12/29/1998US5853973 Structure based designed herbicide resistant products
12/29/1998US5853739 Transmission-blocking vaccine against malaria
12/29/1998US5853737 Method for inducing a CD1-restricted immune response
12/29/1998US5853734 Glycoprotein L and clycoprotein M from kaposi's sarcoma associated herpesvirus, DNA encoding same and uses thereof
12/29/1998US5853725 Prevention and treatment of retroviral disease
12/29/1998US5853724 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
12/29/1998US5853721 Antibody to interleukin-12 receptor
12/29/1998US5853719 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
12/29/1998US5853718 Method of immunization using biologically contained bacterial cells
12/29/1998US5853717 Methods and compositions of growth control for cells encapsulated within bioartificial organs
12/29/1998US5853716 Genetically engineered chimeric viruses for the treatment of diseases associated with viral transactivators
12/29/1998US5853714 Method for purification of IL-12
12/29/1998US5853050 Composition and method for generating a foam barrier and methods of use thereof
12/29/1998CA2171281C Immunomodulating compositions from bile
12/29/1998CA2150265C Activation of p53 protein
12/29/1998CA2148689C Treatment of infertility and enhancement of fertilization capacity in mammalian males
12/29/1998CA2130995C Method for treating macrophage pathogen infections
12/29/1998CA2129554C Recombinant antibodies specific for tnf-.alpha.
12/29/1998CA2038888C Secretion of hirudin derivatives
12/29/1998CA1340297C Conjugation of polymer to colony stimulating factor-1
12/29/1998CA1340296C Cell growth regulatory factor
12/29/1998CA1340295C Human somatomedin carrier protein subunits and process for procucing them
12/29/1998CA1340289C Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies
12/29/1998CA1340288C Generation and selection of novel binding proteins
12/27/1998CA2242086A1 Method of producing a 19p2 ligand
12/26/1998CA2235778A1 Novel glmu
12/26/1998CA2208946A1 Attenuated human immunodeficiency virus vaccine
12/24/1998DE19725847A1 Antikörper gegen FLIP-Protein Antibodies against FLIP protein
12/24/1998DE19725186A1 Herz- und Skelettmuskel-spezifische Nukleinsäure, ihre Herstellung und Verwendung Heart and skeletal muscle-specific nucleic acid, their preparation and use
12/24/1998CA2234418A1 Human afc1
12/24/1998CA2234402A1 Human rce1
12/23/1998WO1998058256A1 PEPTIDO OLIGONUCLEOTIDES (PONs) AND THEIR COMBINATORIAL LIBRARIES
12/23/1998WO1998058082A1 Genetic polymorphisms which are associated with autism spectrum disorders
12/23/1998WO1998058074A2 Assay methods and compositions useful for measuring receptor ligand binding
12/23/1998WO1998058068A2 A method for plant protection against insects or nematodes
12/23/1998WO1998058065A1 Mold-resistant plants and method of construction of same
12/23/1998WO1998058064A1 Kinesin-related protein
12/23/1998WO1998058063A1 Polynucleotides encoding a growth factor-like protein (as amended)
12/23/1998WO1998058062A1 Apo-2DcR
12/23/1998WO1998058061A1 Mammalian genes; related reagents
12/23/1998WO1998058060A1 Human app or a4ct sequences encoding the mutation 145f
12/23/1998WO1998058059A1 Lag-3 splice variants
12/23/1998WO1998058056A1 Cartilage growth agent
12/23/1998WO1998058053A1 Human receptor tyrosine kinase, kdr
12/23/1998WO1998058051A1 Transgenically produced prolactin
12/23/1998WO1998057994A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
12/23/1998WO1998057992A2 Anti-flip protein antibodies
12/23/1998WO1998057991A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998WO1998057990A2 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
12/23/1998WO1998057989A1 Heregulin-like factor
12/23/1998WO1998057988A1 Insecticidal compounds and methods for selection thereof
12/23/1998WO1998057987A2 Irs-p53h, human insulin receptor tyrosine kinase substrate
12/23/1998WO1998057986A2 Human preprotachykinin b
12/23/1998WO1998057985A2 Human rip-interacting factor (rif)
12/23/1998WO1998057984A2 Torsin, torsin genes, and methods of use
12/23/1998WO1998057983A2 Mammalian neuro-growth factor like protein
12/23/1998WO1998057982A2 Aib1, a steroid receptor co-activator
12/23/1998WO1998057981A2 Chlamydia pneumoniae specific peptides and their use in diagnostic assays
12/23/1998WO1998057980A1 Peptides and compounds that bind to the il-5 receptor